Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UFI | US
0.47
6.60%
Consumer Cyclical
Textile Manufacturing
30/06/2024
19/09/2024
7.59
7.17
7.74
7.17
Unifi Inc. together with its subsidiaries manufactures and sells recycled and synthetic products in the United States China Brazil and internationally. Its polyester products include partially oriented yarn textured solution and package dyed twisted beamed and draw wound yarns in virgin or recycled varieties; and nylon products comprise virgin or recycled textured solution dyed and spandex covered yarns. The company also provides recycled solutions made from pre-consumer and post-consumer waste such as plastic bottle flake made from polyester and polymer beads and staple fiber made from polyester or nylon. It offers recycled and synthetic products primarily to yarn manufacturers knitters and weavers that produce fabric for the apparel hosiery home furnishings automotive industrial and other end-use markets. The company sells its products through sales force and independent sales agents under the REPREVE brand. Unifi Inc. was incorporated in 1969 and is headquartered in Greensboro North Carolina.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
65.7%1 month
87.9%3 months
57.7%6 months
57.2%-
54.35
0.45
0.53
0.30
-13.74
0.40
3.01
-4.21M
138.98M
138.98M
-
-0.33
-74.60
4.20
-16.15
3.00
1.41
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.38
Range1M
2.43
Range3M
2.48
Rel. volume
0.87
Price X volume
455.95K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
MultiPlan Corporation | MPLN | Healthcare Plans | 0.2123 | 137.09M | -9.77% | n/a | 753.03% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.35 | 128.70M | 3.85% | n/a | 30.76% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.52 | 125.25M | 4.11% | n/a | 8.14% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.7956 | 119.96M | -6.40% | n/a | -294.40% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8012 | 117.28M | 4.05% | n/a | 36.36% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.5 | 105.61M | 0.29% | n/a | 0.00% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7391 | 92.15M | 0.35% | n/a | -148.05% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 8.625 | 86.99M | 3.17% | n/a | 3.08% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.86 | 85.12M | 0.00% | n/a | 41.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -13.74 | - | - |
Ent. to Revenue | 0.40 | - | - |
PE Ratio | - | - | - |
Price to Book | 0.45 | - | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 57.70 | - | - |
Debt to Equity | 0.53 | - | - |
Debt to Assets | 0.30 | - | - |
Market Cap | 138.98M | - | - |